11699105001
Roche
PCR Buffer Without MgCl2, 10x concentrated
solution, pkg of 3 × 1 mL
Sinônimo(s):
buffer
Faça loginpara ver os preços organizacionais e de contrato
About This Item
Código UNSPSC:
41105600
Produtos recomendados
Formulário
solution
Nível de qualidade
embalagem
pkg of 3 × 1 mL
fabricante/nome comercial
Roche
temperatura de armazenamento
−20°C
Categorias relacionadas
Descrição geral
The PCR buffer without MgCl2, in combination with the MgCl2 stock solution, is used for the individual adjustment of the Mg2+ concentration in the PCR reaction. In most applications a concentration of 1.5mM MgCl2 will yield satisfactory results with a dNTP concentration of 200μM each. In many cases, however, it is required to titrate the optimal Mg2+ concentration to increase the specificity and yield of the PCR reaction.The buffer is ten-fold concentrated and should be used in combination with the MgCl2 stock solution.
Aplicação
The PCR buffer without MgCl2 has been used for the amplification of specific DNA fragments by the polymerase chain reaction (PCR).
forma física
Solution, 100 mM Tris-HCl, 500 mM KCl (pH 8.3 at 20 °C)
Outras notas
For general laboratory use.
Código de classe de armazenamento
12 - Non Combustible Liquids
Classe de risco de água (WGK)
WGK 1
Ponto de fulgor (°F)
does not flash
Ponto de fulgor (°C)
does not flash
Escolha uma das versões mais recentes:
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Os clientes também visualizaram
Omid Yeganeh et al.
Iranian Red Crescent medical journal, 15(4), 340-344 (2013-10-02)
Chlamydia trachomatis and Mycoplasma genitalium infections are the most prevalent sexually transmitted bacterial infections in the world that cause urogenital infections in both men and women. It appears that infertility is a complication of these infections. This study was designed
Rao L Divi et al.
Toxicological sciences : an official journal of the Society of Toxicology, 118(1), 191-201 (2010-08-13)
Mitochondrial compromise has been documented in infants born to women infected with the human immunodeficiency virus (HIV-1) who received nucleoside reverse transcriptase inhibitor (NRTI) therapy during pregnancy. To model these human exposures, we examined mitochondrial integrity at birth and 1
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica